Profiel
Hakim Yadi is the founder of Closed Loop Medicine Ltd., where he currently serves as the Chief Executive Officer & Director.
He founded the company in 2017.
In addition to his current role, Dr. Yadi has also held a former position as a Non-Executive Director at Infex Therapeutics Ltd.
Actieve functies van Hakim Yadi
| Bedrijven | Functie | Begin |
|---|---|---|
Closed Loop Medicine Ltd.
 Closed Loop Medicine Ltd. Pharmaceuticals: MajorHealth Technology Closed Loop Medicine Ltd. operates as a new breed of therapeutics company focused on care pathways, outcomes and the provision of dynamic personalised regimens. It combines proven drugs with digital therapeutics enabling the digitisation and data capture of an entire care continuum. The company was founded by Felicity Sartain, Hakim Yadi, Paul Goldsmith, and David Cox in 2017 and is headquartered in London, the United Kingdom. | Oprichter | 01-01-2017 |
Eerdere bekende functies van Hakim Yadi
| Bedrijven | Functie | Einde |
|---|---|---|
Infex Therapeutics Ltd.
 Infex Therapeutics Ltd. BiotechnologyHealth Technology AMR Centre Ltd. is a British biotechnology research company founded in 2016. The private company is based in Cheshire, UK. The company conducts research in the field of biotechnology. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Infex Therapeutics Ltd.
Infex Therapeutics Ltd. BiotechnologyHealth Technology AMR Centre Ltd. is a British biotechnology research company founded in 2016. The private company is based in Cheshire, UK. The company conducts research in the field of biotechnology. | Health Technology |
Closed Loop Medicine Ltd.
Closed Loop Medicine Ltd. Pharmaceuticals: MajorHealth Technology Closed Loop Medicine Ltd. operates as a new breed of therapeutics company focused on care pathways, outcomes and the provision of dynamic personalised regimens. It combines proven drugs with digital therapeutics enabling the digitisation and data capture of an entire care continuum. The company was founded by Felicity Sartain, Hakim Yadi, Paul Goldsmith, and David Cox in 2017 and is headquartered in London, the United Kingdom. | Health Technology |
